News | November 27, 2022
Early detection of lung cancer vital to combat rising mortality rate, says GlobalData
The only definitive way to diagnose and stage lung cancers is through biopsies
The only definitive way to diagnose and stage lung cancers is through biopsies
Ryzneuta is a novel dimeric G- CSF long-acting fusion protein without pegylation. The Biologics License Application (BLA) of Ryzneuta is currently under late-stage review by the US FDA for Chemotherapy-Induced Neutropenia (CIN)
It will undertake academic and collaborative research activities in Ayurveda, including herbal medicine and yoga, as well as design academic standards, short-term/medium-term courses, and educational guidelines
The company will reduce wastage substantially, increase productivity, enhance environmental consciousness, save energy, optimally use natural resources, and expand its market penetration
Acquisition expands Merck’s growing hematology portfolio
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
The dividend cheque of Rs. 9.93 crore for the Ministry of Ayush was handed over to Sonowal
Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef PARA.
Subscribe To Our Newsletter & Stay Updated
